Qing Qing Yi is on the board of BeiGene Ltd., Hisun Pfizer Pharmaceuticals Co., Ltd. and JD Health International, Inc. and Partner at Hillhouse Capital Group Ltd.

In his past career he held the position of Chairman of Genor Biopharma Holdings Ltd.

Mr. Yi received an undergraduate degree from Shanghai Maritime University and an MBA from the University of Southern California.